Latest information on COVID-19
Support teaching, research, and patient care.
Ann Weinacker is the Senior Vice Chair of Medicine for Clinical Operations; Associate Chief Medical Officer, for Patient Care Services; and she is the Chief Physician Executive of Stanford's Risk Management Department (The Risk Authority). She served as Chief of Staff from 2011-2014 after serving as Vice Chief of Staff from 2010-2011. Dr. Weinacker has extensive experience in SHC clinical and administrative leadership, in addition to serving since 1999 as a full-time faculty member in the Stanford University School of Medicine. She is currently Professor of Medicine in the Division of Pulmonary, Allergy and Critical Care Medicine and is Director of the Intensive Care Units. A strong advocate for patient centricity, Dr. Weinacker was appointed in November 2009 to be one of four leaders designated to actively design, guide and implement strategies to improve the patient experience at Stanford and served in that capacity until 2021. Her research focus is predicting lung transplant outcomes.Dr. Weinacker began her career as a nurse and nurse anesthetist before completing her M.D. at the University of South Alabama College of Medicine, Mobile, in 1986. Her advanced training includes a pulmonary and critical care fellowship and a cardiovascular postdoctoral research fellowship, completed at the University of California, San Francisco in 1994. She is the winner of numerous national honors, editorial posts. Locally, she received the SHC Board of Hospital Director’s coveted Denise O’Leary Award for Clinical Excellence in 2008.
Dr. Weinacker's research interests center around ICU outcomes. Her specific interests include primary graft dysfunction in lung transplant recipients.
Long Term Follow up of the LTOG Cohort
The purpose of the study is to follow participants who enrolled in the Lung Transplant
Outcomes Group. Clinical data, functional assessments, and surveys will be collected to
determine long term graft function and functional status of lung transplant recipients.
Stanford is currently not accepting patients for this trial.
For more information, please contact Gowri Vasudevan, 650-736-8083.
View full details